1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Italy Pharmaceuticals and Healthcare Report Q4 2016

Italy Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates



BMI View: Prescription drugmakers operating in Italy will continue to face revenue challenges asspending by the country's national healthcare service, Servizio Sanitario Nazionale (SSN), continues to berestricted. The government remains committed to remaining under the 3% of GDP budget deficit limit andusing any additional fiscal capacity to ease the tax burden instead of ramping up spending. This willcontinue to negatively impact the healthcare sector and particularly pharmaceutical spending, a largebeneficiary of public funds.

Headline Expenditure Projections

- Pharmaceuticals: EUR28.93bn (USD32.08bn) in 2015 to EUR29.14bn (USD31.18bn) in 2016; +0.73%in local currency terms and -2.8% in US dollar terms.

- Healthcare: EUR150.50bn (USD166.92bn) in 2015 to EUR151.92bn (USD162.55bn) in 2016; +0.9% inlocal currency terms and -2.6% in US dollar terms.

Table Of Contents

Italy Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Italy 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Italy 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020) 16
Prescription Drugs Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020) 21
Generic Drugs Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020) 24
OTC Medicines Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Italy 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Italy 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Italy 2014-2020) 28
Industry Risk Reward Index 29
Western Europe Risk/Reward Index 29
Italy Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 36
Intellectual Property Issues 37
Pricing Regime 38
Reimbursement Regime 42
Market Overview 46
Healthcare Sector 46
Table: Healthcare Resources (Italy 2010-2015) 49
Table: Healthcare Personnel (Italy 2010-2015) 49
Table: Healthcare Activity (Italy 2010-2015) 50
Research and Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 55
Pharmaceutical Distribution 55
Pharmaceutical Retail Sector 56
Company Profile 58
GlaxoSmithKline 58
Menarini 60
Novartis 63
Pfizer 66
Recordati 68
Demographic Forecast 71
Table: Population Headline Indicators (Italy 1990-2025) 72
Table: Key Population Ratios (Italy 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Italy 1990-2025) 73
Table: Population By Age Group (Italy 1990-2025) 73
Table: Population By Age Group % (Italy 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.